Lacosamide
- Product NDC
- 16714-548
- 11-digit product format
- 167140548
- Labeler code
- 16714
- Product ID
- 16714-548_ad8753cb-70b7-431e-9d52-93558d469ef5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lacosamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA208308
- Marketing category
- ANDA
- Marketing start
- 2022-08-01
- Substance
- LACOSAMIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lacosamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LACOSAMIDE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 563KS2PQY5 |
| Rxcui | 809987, 809992, 809996, 810000 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16714-548-01 | Lacosamide | 60 in 1 BOTTLE | TABLET | 60 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16714-548 | LACOSAMIDE TABLET [NORTHSTAR RXLLC] | 6 | Current NDC, Legacy NDC, 1 package rows | 20250125_9dffda6c-9e44-478f-9e02-9da3ab4c50e1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-548-01 | 16714054801 | 60 TABLET in 1 BOTTLE (16714-548-01) | 60 tablet | 2022-08-01 | 0000-00-00 | No | No | Current |